| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Corporate Controller
1 company
Trojanowski Justin serves as a Corporate Controller at TPST. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $20K at current prices.
The biggest single holding is TPST (~$20K) as Corporate Controller. Net of sales, the recent Form 4 record there shows accumulation of 7,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28, 2024 | TPST Tempest Therapeutics, Inc. | Corporate Controller | Buy | 7,500 | $2.16 | $16,200.00 | +51.1% | -40.6% | -75.8% |